KalVista Pharmaceuticals (KALV) Shares Outstanding (Diluted Average) (2020 - 2025)

KalVista Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $53.5 million for Q3 2025.

• In Q3 2025, Shares Outstanding (Diluted Average) rose 15.71% year-over-year to $53.5 million; the TTM figure through Jul 2025 stood at $53.5 million (up 15.71% YoY), while the FY2025 annual figure was $49.7 million, up 34.98% from the prior year.
• Shares Outstanding (Diluted Average) came in at $53.5 million for Q3 2025 at KalVista Pharmaceuticals, up from $49.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $53.5 million in Q3 2025 to a low of $19.1 million in Q2 2021.
• A 5-year average of $32.9 million and a median of $28.3 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) increased 0.52% in 2022 and soared 40.54% in 2023, its largest moves.
• KalVista Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $24.4 million in 2021, then grew by 0.66% to $24.6 million in 2022, then jumped by 40.54% to $34.6 million in 2023, then jumped by 35.09% to $46.7 million in 2024, then climbed by 14.57% to $53.5 million in 2025.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $53.5 million, $49.7 million, and $46.7 million for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison